Seguir
Diego Daniel Manavella
Diego Daniel Manavella
Otros nombresDiego Manavella
MD, PhD - Department of Obstetrics and Gynecology, Jacobs School of Medicine and Biomedical Sciences
Dirección de correo verificada de buffalo.edu
Título
Citado por
Citado por
Año
Recent advances in fertility preservation
MM Dolmans, DD Manavella
Journal of Obstetrics and Gynaecology Research 45 (2), 266-279, 2019
1102019
Adipose tissue-derived stem cells in a fibrin implant enhance neovascularization in a peritoneal grafting site: a potential way to improve ovarian tissue transplantation
DD Manavella, L Cacciottola, CM Desmet, BF Jordan, J Donnez, ...
Human Reproduction 33 (2), 270-279, 2018
672018
Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen–thawed human ovarian tissue
DD Manavella, L Cacciottola, S Pommé, CM Desmet, BF Jordan, ...
Human Reproduction 33 (6), 1107-1116, 2018
662018
In vivo characterization of metabolic activity and oxidative stress in grafted human ovarian tissue using microdialysis
L Cacciottola, DD Manavella, CA Amorim, J Donnez, MM Dolmans
Fertility and sterility 110 (3), 534-544. e3, 2018
522018
Role of the PI3K and Hippo pathways in follicle activation after grafting of human ovarian tissue
R Masciangelo, C Hossay, MC Chiti, DD Manavella, CA Amorim, ...
Journal of assisted reproduction and genetics 37, 101-108, 2020
502020
Techniques for ovarian tissue transplantation and results.
J Donnez, DD Manavella, MM Dolmans
Minerva ginecologica 70 (4), 424-431, 2018
302018
Endometrial cancer in reproductive age: fertility-sparing approach and reproductive outcomes
L Mutlu, DD Manavella, G Gullo, B McNamara, AD Santin, P Patrizio
Cancers 14 (21), 5187, 2022
292022
Adipose tissue-derived stem cells boost vascularization in grafted ovarian tissue by growth factor secretion and differentiation into endothelial cell lineages
DD Manavella, L Cacciottola, VL Payen, CA Amorim, J Donnez, ...
MHR: Basic science of reproductive medicine 25 (4), 184-193, 2019
272019
Translational research aiming to improve survival of ovarian tissue transplants using adipose tissue‐derived stem cells
MM Dolmans, L Cacciottola, CA Amorim, D Manavella
Acta obstetricia et gynecologica Scandinavica 98 (5), 665-671, 2019
202019
Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate …
JR Tymon-Rosario, P Manara, DD Manavella, S Bellone, TMP Hartwich, ...
Gynecologic Oncology 166 (1), 117-125, 2022
132022
Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu
G Yadav, DM Roque, S Bellone, DD Manavella, TMP Hartwich, M Zipponi, ...
Gynecologic Oncology 166 (2), 351-357, 2022
122022
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian …
D Mauricio, S Bellone, L Mutlu, B McNamara, DD Manavella, ...
Gynecologic oncology 170, 38-45, 2023
102023
Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma
J Harold, S Bellone, DD Manavella, L Mutlu, B McNamara, TMP Hartwich, ...
Gynecologic oncology 168, 157-165, 2023
92023
Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor
B McNamara, J Harold, D Manavella, S Bellone, L Mutlu, TMP Hartwich, ...
Gynecologic Oncology 172, 65-71, 2023
22023
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor
DD Manavella, B McNamara, J Harold, S Bellone, TMP Hartwich, ...
Gynecologic Oncology 169, 98-105, 2023
22023
Disease-inducing potential of two leukemic cell lines in a xenografting model
DD Manavella, S Herraiz, M Soares, A Buigues, A Pellicer, J Donnez, ...
Journal of Assisted Reproduction and Genetics 38, 1589-1600, 2021
22021
EP015/# 546 In vitro and in vivo efficacy of trastuzumab deruxtecan (T-DXd) in epithelial ovarian cancer with HER2/NEU overexpression
L Mutlu, D Manavella, S Bellone, A Santin
International Journal of Gynecological Cancer 32 (Suppl 3), A54-A54, 2022
12022
Pregnancy and live birth rates in young women with diminished ovarian reserve
GD Manavella, DD Manavella, O Ruiz V
Revista científica ciencias de la salud 3 (1), 6-13, 2021
12021
Tasas de embarazo y nacido vivo en mujeres jóvenes infértiles con baja reserva ovárica
GD Manavella, DD Manavella, O Ruiz
Revista científica ciencias de la salud 3 (1), 6-13, 2021
12021
The role of Akt and mTOR pathways in follicle activation after grafting of human ovarian tissue
R Masciangelo, C Hossay, MC Chiti, DD Manavella, CA Amorim, ...
HUMAN REPRODUCTION 34, 349-350, 2019
12019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20